Get started
Gilead Sciences, Inc.Gilead Sciences, Inc.Gilead Sciences, Inc.

Gilead Sciences, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

GILD chart


Full chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪105.76 B‬USD
Dividend yield (indicated)
3.63%
Price to earnings Ratio (TTM)
103.48
Basic EPS (TTM)
0.84USD
Net income (FY)
‪5.66 B‬USD
Revenue (FY)
‪27.06 B‬USD
Shares float
‪1.24 B‬
Beta (1Y)
0.35

Employees


Employees (FY)
‪18 K‬
Revenue / Employee (1Y)
‪1.50 M‬USD
Net income / Employee (1Y)
‪314.67 K‬USD

About Gilead Sciences, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Daniel P. O'Day
Website
gilead.com
Headquarters
Foster City
Founded
1987
FIGI
BBG000CKGBP2
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas



See all ideas 

News



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Analyze a symbol's price movements over past years with our seasonal tools, helping you spot repeating annual trends and better gauge potential market patterns.

Highest yielding bonds


US375558CA9
GILEAD SCIEN 23/53
GISE
GILEAD SCIENCES 2046
US375558BK8
GILEAD SCIENCES 16/47
GILD.GO
Gilead Sciences, Inc. 5.65% 01-DEC-2041
US375558AX1
GILEAD SCIENCES 14/44
US375558BS1
GILEAD SCIEN 20/40
GISA
GILEAD SCIENCES 14/45
GISG
GILEAD SCIENCES 16/36
GILD5050849
Gilead Sciences, Inc. 2.8% 01-OCT-2050
GISF
GILEAD SCIENCES 2035
US375558BZ5
GILEAD SCIEN 23/33

Explore more bonds 

Sparks


Curated watchlists where GILD is featured.

See all sparks 

Frequently Asked Questions


The current price of GILD is 85.05 USD — it has increased by 0.33% in the past 24 hours. Watch Gilead Sciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Gilead Sciences, Inc. stocks are traded under the ticker GILD.
GILD stock has risen by 0.72% compared to the previous week, the month change is a 4.70% rise, over the last year Gilead Sciences, Inc. has showed a 10.18% increase.
We've gathered analysts' opinions on Gilead Sciences, Inc. future price: according to them, GILD price has a max estimate of 123.00 USD and a min estimate of 69.00 USD. Watch GILD chart and read a more detailed Gilead Sciences, Inc. stock forecast: see what analysts think of Gilead Sciences, Inc. and suggest that you do with its stocks.
GILD reached its all-time high on Jun 24, 2015 with the price of 123.37 USD, and its all-time low was 0.21 USD and was reached on Jun 8, 1994. View more price dynamics on GILD chart.
See other stocks reaching their highest and lowest prices.
GILD stock is 1.19% volatile and has beta coefficient of 0.35. Track Gilead Sciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Gilead Sciences, Inc. there?
Today Gilead Sciences, Inc. has the market capitalization of ‪105.76 B‬, it has increased by 0.89% over the last week.
Yes, you can track Gilead Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
Gilead Sciences, Inc. is going to release the next earnings report on Nov 6, 2024. Keep track of upcoming events with our Earnings Calendar.
GILD earnings for the last quarter are 2.01 USD per share, whereas the estimation was 1.61 USD resulting in a 25.05% surprise. The estimated earnings for the next quarter are 1.55 USD per share. See more details about Gilead Sciences, Inc. earnings.
Gilead Sciences, Inc. revenue for the last quarter amounts to ‪6.95 B‬ USD, despite the estimated figure of ‪6.70 B‬ USD. In the next quarter, revenue is expected to reach ‪6.99 B‬ USD.
GILD net income for the last quarter is ‪1.61 B‬ USD, while the quarter before that showed ‪−4.17 B‬ USD of net income which accounts for 138.71% change. Track more Gilead Sciences, Inc. financial stats to get the full picture.
Yes, GILD dividends are paid quarterly. The last dividend per share was 0.77 USD. As of today, Dividend Yield (TTM)% is 3.60%. Tracking Gilead Sciences, Inc. dividends might help you take more informed decisions.
Gilead Sciences, Inc. dividend yield was 3.70% in 2023, and payout ratio reached 66.62%. The year before the numbers were 3.40% and 80.25% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 15, 2024, the company has ‪18.00 K‬ employees. See our rating of the largest employees — is Gilead Sciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Gilead Sciences, Inc. EBITDA is ‪12.88 B‬ USD, and current EBITDA margin is 45.96%. See more stats in Gilead Sciences, Inc. financial statements.
Like other stocks, GILD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Gilead Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Gilead Sciences, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Gilead Sciences, Inc. stock shows the strong buy signal. See more of Gilead Sciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.